Le Lézard
Classified in: Health
Subject: PER

CCO Welcomes Katie Eustace, Senior Director, Global Medical Education


RESTON, Va., Nov. 14, 2018 /PRNewswire-PRWeb/ -- Clinical Care Options (CCO) is pleased to announce the appointment of Katie Eustace (Owrey) as Senior Director, Global Medical Education, Europe. Katie has more than 18 years of experience in several medical education senior business development and project management positions. In Katie's role with CCO, she will provide strategic consulting to supporters to design independent medical education to ultimately impact clinical outcomes for patients throughout Europe. Katie will be responsible for the expansion of the company's innovative and unique IME/CME programs in European markets across several therapeutic areas, including oncology/hematology.

Prior to joining CCO, Katie served as Vice President, Global Educational Development at prIME Oncology, where she was responsible for growing and managing global business opportunities with multiple key stakeholders. Katie resides and has worked in the European market for more than 7 years, giving her tangible perspective into the global medical education space.

Before prIME Oncology, she held a number of key business development and project management roles with various medical education companies in the United States of America before moving to the Netherlands.

"Katie has shown a remarkable ability to develop industry relationships and partnerships in the continuing education market," said Robin Murray, President of CCO. "As we continue our global education expansion, we are excited to have Katie on the team."

About Clinical Care Options:
Clinical Care Options, LLC, is a global leader in the development of innovative educational programs and technology platforms. CCO's team has been a pioneer in the creation of continuing education and decision support resources for healthcare professionals both in the United States and around the world for more than 2 decades. For more information, visit clinicaloptions.com.

Contact:
Tradd Sanderson | Director of Marketing
Clinical Care Options
Telephone: 855.224.2241
Email: tsanderson(at)clinicaloptions.com

 

SOURCE Clinical Care Options


These press releases may also interest you

at 16:28
Dr. Siva Mohan, Co-Founder and Chief Medical Officer of RazorMetrics, an Austin-based drug cost reduction platform, is the Best Entrepreneur - Health Products & Services Status: Silver Stevie Winner from the American Business Awards. The Stevie®...

at 16:20
The Board of Directors of Revvity , today declared a regular quarterly dividend of $0.07 per share of common stock. This dividend is payable on August 9, 2024 to all shareholders of record at the close of business on July 19, 2024. About Revvity ...

at 16:20
Edwards Lifesciences today reported financial results for the quarter ended March 31, 2024. Highlights and Outlook Q1 sales grew 10% on a reported and constant currency1 basis to $1.6 billion Q1 TAVR sales grew 6%; constant currency sales...

at 16:16
A functional assessment of Bacillus subtilis PLSSC (SEBtilistm) demonstrated its antimicrobial activity and capability to offer health benefits through industrial processing and the digestion process, showing its value-add in functional foods,...

at 16:15
Cronos Group Inc. ("Cronos" or the "Company") will hold its 2024 first quarter earnings conference call on Thursday, May 9, 2024 at 8:30 a.m. ET. Cronos' senior management team will discuss the Company's financial results and will be available for...

at 16:05
Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a global messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases, today...



News published on and distributed by: